24 September 2020 - The chief executive of AstraZeneca has said the public must trust that multiple regulators will review the safety of COVID-19 vaccines, confirming the company is still waiting for the US regulator to review safety data after its vaccine trial was paused.

Pascal Soriot told the World Economic Forum's Sustainable Development Impact Summit on Thursday the global biotechnology firm was considering how much transparency it could provide about its vaccine trials, after its phase 3 study was put on hold earlier this month because of an adverse reaction in a participant.

Read Sydney Morning Herald article